Daratumumab resistance is frequent in advanced stage multiple myeloma patients irrespectively of CD38 expression, and is related to dismal prognosis.
| Image |  |
|---|---|
| Description | scientific article published on 17 February 2018 |
| Author/s |
author: Moshe E Gatt |
| Publication date | March 25, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |